Physician profile
Alhamza R Al-Bayati
NPI 1104121227
$66,172.71
in general payments reported to CMS, 2019-2025
14 companies · $35K in 2025
The $35K reported for 2025 was more than what 96% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.65 · 2021: $1,059 · 2022: $398 · 2023: $17K · 2024: $14K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Travel and Lodging: $22K · Food and Beverage: $1,952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,245.76 |
| Travel and Lodging | $22,487.31 |
| Food and Beverage | $1,952.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $55,743.75 | 2023-2025 | Emboguard, Cerepak Uniform, Neuroscout |
| Scientia Vascular | $7,192.36 | 2025 | |
| Stryker Corporation | $1,567.75 | 2021-2023 | Axs Vecta 71, Universal Neuro 3 |
| Microvention, INC. | $475.41 | 2022-2025 | Azur Cx Detachable, Web Aneurysm Embolization System |
| Balt USA, LLC | $292.56 | 2023-2025 | Optima Coil System |
| Viz.Ai, INC. | $241.71 | 2021 | |
| Depuy Synthes Sales INC. | $229.38 | 2022-2024 | Trufill |
| Route 92 Medical, INC. | $130.00 | 2022 | |
| Medtronic, INC. | $91.86 | 2024-2025 | Pipeline, Onyx 18 |
| Astrazeneca Pharmaceuticals Lp | $85.00 | 2022 | |
| Phenox INC. | $67.22 | 2021 | |
| Medtronic USA, INC. | $30.65 | 2020 | |
| Penumbra, INC. | $25.06 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alhamza Al-Bayati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.